Orthocell’s autologous tendon cell therapy is the most advanced injectable cellular therapy for the treatment of chronic tendon injuries.

The patient’s own healthy tendon derived cells are used to assist in the regeneration of damaged tendon to reduce pain and return function. The innovative therapy addresses a significant unmet clinical need for a safe, effective, and non-surgical solution to treat tendon injuries. This product is not currently listed on the ARTG.

How It Works

 Autologous cell therapy involves collecting a small sample of the same tissue type that needs repair, isolating the required cells, growing those cells in a specialised laboratory, and then implanting them back into the area of injury. The aim is to support the body’s natural repair processes using the patient’s own cells